Basit öğe kaydını göster

dc.contributor.authorBacanak, Merve Saygi
dc.date.accessioned2021-03-03T14:45:16Z
dc.date.available2021-03-03T14:45:16Z
dc.date.issued2018
dc.identifier.citationBacanak M. S. , "Muscarinic M1 and M2 receptors, fasting and seizure development in animals", CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.8, sa.4, ss.308-313, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_3b3eae4d-1d89-4b2d-851f-1ac4fc5cd9b6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/43798
dc.description.abstractMuscarinic M-1 and M-2 receptors are widely distributed in the brain and contribute to various physiological and pathological functions. It is well known that enhancement of cholinergic activity produces convulsions in animals. Pilocarpine, the M-1 muscarinic receptor agonist, is commonly used to induce seizures in rodents. On the other hand it has been reported that fasted rats and mice pretreated with the M-1 and M-2 receptor antagonist atropine, scopolamine or biperiden develop convulsions after food intake indicating cholinergic hypoactivity as the underlying mechanism. This review will present pharmacological data for the M-1 and M-2 receptors in the brain and focus on the contrasting findings related to their contribution to convulsions.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.titleMuscarinic M1 and M2 receptors, fasting and seizure development in animals
dc.typeMakale
dc.relation.journalCLINICAL AND EXPERIMENTAL HEALTH SCIENCES
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume8
dc.identifier.issue4
dc.identifier.startpage308
dc.identifier.endpage313
dc.contributor.firstauthorID249399


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster